Global Health recommends the use of the AstraZeneca vaccine and stresses: The benefits outweigh the risks

The World Health Organization (WHO) vaccine safety committee said today, Wednesday, that it believes that the benefits of using the AstraZeneca vaccine to prevent Covid-19 outweigh the risks and recommends that immunization be continued.

The World Health Organization had included a vaccine produced by AstraZeneca in cooperation with the University of Oxford in the list of emergency use last month, making it available on a wider scale to the developing world due to its low price, but more than 12 European countries stopped using the vaccine this week after concerns arose about the effects Possible side.

The European Medicines Agency said it was investigating reports of 30 cases of unusual blood function disorders out of the five million who received the vaccine, and a total of 45 million doses of AstraZeneca vaccine were distributed across the region.

The European Agency, which is the regulatory body responsible for licensing medicines and vaccines, is scheduled to announce its findings on Thursday, but its president, Emir Kok, said that it does not see a reason to change the recommendation regarding the AstraZeneca vaccine, one of the four vaccines that the agency has approved to use so far to prevent the disease.

The World Health Organization said that the Global Vaccine Safety Advice Committee is carefully examining the latest available data on the safety of the AstraZeneca vaccine.

"Once the review is completed, the World Health Organization will publish the results immediately," the World Health Organization said in a statement a day after its experts held a closed meeting.

"Until now, the World Health Organization (WHO) considers the benefits of using the AstraZeneca vaccine to outweigh the risks, and recommends the continuation of the vaccination campaigns," the statement added.